A peripheral vascular stent is an expandable perforated tube which is inserted into a peripheral vessel to prevent blood flow constriction.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Peripheral Vascular Stents under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Peripheral Vascular Stents and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to Buy
The report enables you to:
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
- Identify and understand important and diverse types of Peripheral Vascular Stents under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
Table of Contents
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- 3D Biotek LLC
- Abbott Vascular Inc
- Acotec Scientific Holdings Ltd
- amg International GmbH
- AndraTec GmbH
- Arterius Ltd
- Becton Dickinson and Co
- Biotyx Medical (Shenzhen) Co Ltd
- Boston Scientific Corp
- Cook Medical Inc
- Cordis US Corp
- CorInnova, Inc.
- Cytograft Tissue Engineering Inc (Inactive)
- Efemoral Medical LLC
- Efferent Labs Inc
- Electroformed Stents Inc
- Elixir Medical Corp
- Endomimetics LLC
- FIT Biotech Oy (Inactive)
- HeMo Bioengineering Ltd
- ID Nest Medical SAS
- InspireMD Inc
- Intressa Vascular SA
- Kyoto Medical Planning Co Ltd
- LeoMed, LLC
- Lepu Medical Technology (Beijing) Co Ltd
- LimFlow SA
- Lyra Therapeutics Inc
- Meril Life Sciences Pvt Ltd
- Micell Technologies Inc
- Micro Medical Solutions Inc
- Natec Medical Ltd
- Nipro Corp
- NSVascular, Inc.
- OrbusNeich
- PeriTec Biosciences Ltd
- QualiMed Innovative Medizinprodukte GmbH
- Qvanteq AG
- Reflow Medical, Inc.
- Shanghai Bio-heart Biological Technology Co Ltd
- Shanghai Easy-Flow Medical Tech Co Ltd
- Shanghai MicroPort Endovascular MedTech Group Co Ltd
- Shenzhen Salubris Pharmaceuticals Co Ltd
- Suzhou Fengzhi Medical Technology Co Ltd
- Suzhou Yinluo Medical Devices Co Ltd
- Synergy Flow Ltd
- Tepha Inc
- Terumo Corp
- TissueGen Inc
- Tractivus SL
- University of Michigan
- University of Pittsburgh
- University of Pittsburgh Medical Center
- Vascular Bioresorbable Technologies
- Vascular Concepts Ltd
- Vesper Medical Inc
- VINNOVA
- VueKlar Cardiovascular Ltd (Inactive)
- Wake Forest University Health Sciences
- Xenogenics Corporation
- Zorion Medical
- Zylox-Tonbridge Medical Technology Co Ltd